• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胰腺腺癌与健康胰腺组织的差异表达谱分析。

Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue.

作者信息

Lu ZhaoHui, Hu LiPing, Evers Stefan, Chen Jie, Shen Yan

机构信息

Department of Pathology, Peking Union Medical College Hospital, Beijing, PR China.

出版信息

Proteomics. 2004 Dec;4(12):3975-88. doi: 10.1002/pmic.200300863.

DOI:10.1002/pmic.200300863
PMID:15526344
Abstract

Due to poor prognosis and lack of effective treatment, pancreatic carcinoma (PC) is a devastating disease. With the goal of contributing to an improved detection, prevention and treatment of the disease, a comparative proteome analysis of PC and normal tissue was carried out. Paired tissue extracts from 12 patients (pancreatic adenocarcinoma and adjacent healthy tissue) were separated by two-dimensional electrophoresis. Differential protein expression was analyzed by gel comparison with the help of image analysis software. The differentially expressed spots were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Seventy proteins were more strongly expressed (mostly two-fold or more) in cancerous tissue, while 41 were stronger in normal pancreas respectively. Those spots highly expressed in PC were confirmed in gels from independent individual samples. Among them were several cytoskeletal proteins, small GTP-binding proteins, and members of the S100 protein family etc. Nine proteins had been reported in previous nuclear acid-based studies. The levels of two proteins were confirmed by immunohistochemistry. One of them, fascin, was detected in 13 out of 21 carcinoma and negative in all normal pancreas samples. Moreover, fascin expression was related to the differentiation of pancreatic carcinoma.

摘要

由于预后较差且缺乏有效的治疗方法,胰腺癌(PC)是一种极具毁灭性的疾病。为了有助于改善该疾病的检测、预防和治疗,我们对胰腺癌组织和正常组织进行了比较蛋白质组分析。从12名患者(胰腺腺癌和相邻健康组织)获取的配对组织提取物通过二维电泳进行分离。借助图像分析软件,通过凝胶比较分析差异蛋白表达。通过基质辅助激光解吸/电离飞行时间质谱法鉴定差异表达的斑点。70种蛋白质在癌组织中表达更强(大多为两倍或更高),而41种在正常胰腺中表达更强。在独立个体样本的凝胶中证实了那些在胰腺癌中高表达的斑点。其中包括几种细胞骨架蛋白、小GTP结合蛋白和S100蛋白家族成员等。在先前基于核酸的研究中已报道了9种蛋白质。通过免疫组织化学证实了两种蛋白质的水平。其中一种,即丝聚蛋白,在21例癌组织中的13例中检测到,在所有正常胰腺样本中均为阴性。此外,丝聚蛋白的表达与胰腺癌的分化有关。

相似文献

1
Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue.人胰腺腺癌与健康胰腺组织的差异表达谱分析。
Proteomics. 2004 Dec;4(12):3975-88. doi: 10.1002/pmic.200300863.
2
Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.激光捕获显微切割联合二维电泳在胰腺导管腺癌差异表达蛋白发现中的应用
Proteomics. 2003 Oct;3(10):1988-2001. doi: 10.1002/pmic.200300466.
3
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.利用差异凝胶电泳和串联质谱法对人胰腺癌血清中的蛋白质进行表征分析。
J Proteome Res. 2005 Sep-Oct;4(5):1742-51. doi: 10.1021/pr050174l.
4
MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.基质辅助激光解吸电离成像质谱分析揭示 COX7A2、TAGLN2 和 S100-A10 是 Barrett 腺癌的新型预后标志物。
J Proteomics. 2012 Aug 3;75(15):4693-704. doi: 10.1016/j.jprot.2012.02.012. Epub 2012 Feb 17.
5
Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins.通过二维凝胶电泳和基质辅助激光解吸/电离质谱对人肝肿瘤组织进行蛋白质组分析以鉴定疾病相关蛋白。
Electrophoresis. 2002 Dec;23(24):4142-56. doi: 10.1002/elps.200290032.
6
Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.
Hepatobiliary Pancreat Dis Int. 2009 Apr;8(2):193-200.
7
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.通过蛋白质芯片技术鉴定肝癌-肠-胰腺/胰腺炎相关蛋白I作为胰腺导管腺癌的生物标志物
Cancer Res. 2002 Mar 15;62(6):1868-75.
8
Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.使用 2D-DIGE 和 MALDI-TOF-MS 分析胰腺导管腺癌的潜在肿瘤标志物:补体 C3 和α-2-HS-糖蛋白的上调。
Pancreatology. 2013 May-Jun;13(3):290-7. doi: 10.1016/j.pan.2013.03.010. Epub 2013 Mar 15.
9
Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.牛胰腺导管细胞体外恶性转化过程中差异表达的基因和蛋白质。
Neoplasia. 2007 Feb;9(2):136-46. doi: 10.1593/neo.06754.
10
Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.鉴定胰液蛋白作为胰腺癌的生物标志物。
Oncol Rep. 2010 Jun;23(6):1683-92. doi: 10.3892/or_00000812.

引用本文的文献

1
FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.FSCN1作为肿瘤细胞运动阻断的一个有前景的治疗靶点:其功能、机制及临床意义综述
J Cancer. 2022 May 9;13(8):2528-2539. doi: 10.7150/jca.67977. eCollection 2022.
2
Emerging Role of Fascin-1 in the Pathogenesis, Diagnosis, and Treatment of the Gastrointestinal Cancers.Fascin-1在胃肠道癌症发病机制、诊断及治疗中的新作用
Cancers (Basel). 2021 May 21;13(11):2536. doi: 10.3390/cancers13112536.
3
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy.
鉴定胰腺肿瘤组织中的新型生物标志物以预测对新辅助化疗的反应。
Front Oncol. 2020 Mar 4;10:237. doi: 10.3389/fonc.2020.00237. eCollection 2020.
4
A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO.一种基于磷脂双层与二氧化钛之间的特异性相互作用进行简便血清外泌体分离的新策略。
Chem Sci. 2018 Dec 3;10(6):1579-1588. doi: 10.1039/c8sc04197k. eCollection 2019 Feb 14.
5
Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor Screening.量子点掺杂诱导的光致发光用于简便、无标记且灵敏的焦磷酸酶活性测定及抑制剂筛选。
Nanomaterials (Basel). 2019 Jan 18;9(1):111. doi: 10.3390/nano9010111.
6
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.使用蛋白质组多标志物组合提高胰腺癌的诊断性能
Oncotarget. 2017 Oct 16;8(54):93117-93130. doi: 10.18632/oncotarget.21861. eCollection 2017 Nov 3.
7
Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stress.癌症、缺氧和高渗应激中的化学成分及蛋白质组学转化潜力。
PeerJ. 2017 Jun 6;5:e3421. doi: 10.7717/peerj.3421. eCollection 2017.
8
Pancreatic cancer stem cell markers and exosomes - the incentive push.胰腺癌干细胞标志物与外泌体——激励因素
World J Gastroenterol. 2016 Jul 14;22(26):5971-6007. doi: 10.3748/wjg.v22.i26.5971.
9
Strategies for early detection of resectable pancreatic cancer.可切除胰腺癌的早期检测策略。
World J Gastroenterol. 2014 Aug 28;20(32):11230-40. doi: 10.3748/wjg.v20.i32.11230.
10
Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.胰腺癌的遗传和分子改变:对个性化医学的启示。
Med Sci Monit. 2013 Oct 31;19:916-26. doi: 10.12659/MSM.889636.